Clinical Trial Update: Cardioprotective Effects of Melatonin in Patients With Cardiomyopathy [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating the cardioprotective effects of melatonin in patients with cardiomyopathy; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiomyopathy

Drugs mentioned

• Melatonin (melatonin)

Snippet

Sponsor: Tanta University | Conditions: Cardiomyopathies | Phase 3 | Status: RECRUITING